These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19570310)

  • 1. Ecological assessment of executive functions in mild cognitive impairment and mild Alzheimer's disease.
    Espinosa A; Alegret M; Boada M; Vinyes G; Valero S; Martínez-Lage P; Peña-Casanova J; Becker JT; Wilson BA; Tárraga L
    J Int Neuropsychol Soc; 2009 Sep; 15(5):751-7. PubMed ID: 19570310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecological evaluation of executive functions in mild cognitive impairment and Alzheimer disease.
    da Costa Armentano CG; Porto CS; Nitrini R; Dozzi Brucki SM
    Alzheimer Dis Assoc Disord; 2013; 27(2):95-101. PubMed ID: 22828321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability study of the Behavioral Assessment of the Dysexecutive Syndrome adapted for a Brazilian sample of older-adult controls and probable early Alzheimer's disease patients.
    Canali F; Brucki SM; Bertolucci PH; Bueno OF
    Braz J Psychiatry; 2011 Dec; 33(4):338-46. PubMed ID: 21584345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the Behavioural Assessment of the Dysexecutive Syndrome (BADS) performance in healthy individuals, Mild Cognitive Impairment and Alzheimer's disease: A preliminary study.
    Armentano CGDC; Porto CS; Brucki SMD; Nitrini R
    Dement Neuropsychol; 2009; 3(2):101-107. PubMed ID: 29213619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropsychological impairment in the early Alzheimer's disease].
    Traykov L; Rigaud AS; Cesaro P; Boller F
    Encephale; 2007; 33(3 Pt 1):310-6. PubMed ID: 17675928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural assessment of the dysexecutive syndrome (BADS) in healthy elders and Alzheimer's disease patients: preliminary study.
    Canali F; Brucki SMD; Bueno OFA
    Dement Neuropsychol; 2007; 1(2):154-160. PubMed ID: 29213382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of neuropsychological impairment in MCI patients with small subcortical infarcts or hippocampal atrophy.
    Gainotti G; Ferraccioli M; Vita MG; Marra C
    J Int Neuropsychol Soc; 2008 Jul; 14(4):611-9. PubMed ID: 18577290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain perfusion correlates of visuoperceptual deficits in mild cognitive impairment and mild Alzheimer's disease.
    Alegret M; Vinyes-Junqué G; Boada M; Martínez-Lage P; Cuberas G; Espinosa A; Roca I; Hernández I; Valero S; Rosende-Roca M; Mauleón A; Becker And JT; Tárraga L
    J Alzheimers Dis; 2010; 21(2):557-67. PubMed ID: 20555146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.
    Dierckx E; Engelborghs S; De Raedt R; De Deyn PP; Ponjaert-Kristoffersen I
    Psychol Med; 2007 May; 37(5):747-55. PubMed ID: 17164030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
    Grundman M; Petersen RC; Ferris SH; Thomas RG; Aisen PS; Bennett DA; Foster NL; Jack CR; Galasko DR; Doody R; Kaye J; Sano M; Mohs R; Gauthier S; Kim HT; Jin S; Schultz AN; Schafer K; Mulnard R; van Dyck CH; Mintzer J; Zamrini EY; Cahn-Weiner D; Thal LJ;
    Arch Neurol; 2004 Jan; 61(1):59-66. PubMed ID: 14732621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
    Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
    Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive predictors of financial capacity across the dementia spectrum: Normal aging, mild cognitive impairment, and Alzheimer's disease.
    Sherod MG; Griffith HR; Copeland J; Belue K; Krzywanski S; Zamrini EY; Harrell LE; Clark DG; Brockington JC; Powers RE; Marson DC
    J Int Neuropsychol Soc; 2009 Mar; 15(2):258-67. PubMed ID: 19203439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The heterogeneity of mild cognitive impairment: a neuropsychological analysis.
    Libon DJ; Xie SX; Eppig J; Wicas G; Lamar M; Lippa C; Bettcher BM; Price CC; Giovannetti T; Swenson R; Wambach DM
    J Int Neuropsychol Soc; 2010 Jan; 16(1):84-93. PubMed ID: 19887015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging of the cognitive decline in Alzheimer's disease: insights from a detailed neuropsychological investigation of mild cognitive impairment and mild Alzheimer's disease.
    Carter SF; Caine D; Burns A; Herholz K; Lambon Ralph MA
    Int J Geriatr Psychiatry; 2012 Apr; 27(4):423-32. PubMed ID: 21618285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes.
    Di Iulio F; Palmer K; Blundo C; Casini AR; Gianni W; Caltagirone C; Spalletta G
    Int Psychogeriatr; 2010 Jun; 22(4):629-40. PubMed ID: 20367890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls.
    Schrijnemaekers AM; de Jager CA; Hogervorst E; Budge MM
    J Clin Exp Neuropsychol; 2006 Apr; 28(3):438-55. PubMed ID: 16618630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivity of cortical alpha rhythms to eye opening in mild cognitive impairment and Alzheimer's disease: an EEG study.
    Babiloni C; Lizio R; Vecchio F; Frisoni GB; Pievani M; Geroldi C; Claudia F; Ferri R; Lanuzza B; Rossini PM
    J Alzheimers Dis; 2010; 22(4):1047-64. PubMed ID: 20930306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is mild cognitive impairment prodromal for vascular dementia like Alzheimer's disease?
    Meyer JS; Xu G; Thornby J; Chowdhury MH; Quach M
    Stroke; 2002 Aug; 33(8):1981-5. PubMed ID: 12154249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated Neuropsychological Test Battery (CANTAB) in mild cognitive impairment and in Alzheimer's disease.
    Egerházi A; Berecz R; Bartók E; Degrell I
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):746-51. PubMed ID: 17289240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.